Dynavax Technologies Corporation
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes o…
Drug Manufacturers - Specialty & Generic
US, EmeryVille [HQ]
Ratios
15 Sheets · From 2023 to 2009Configuration
Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 97.57 | 95.91 | 98.62 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | -265.14 | -165.87 | 44.95 | 70.12 | 60.50 | 63.73 | 78.40 | |
| Profit Margin | -75.81 | -239.28 | -224.84 | -720.08 | -593.01 | -822.35 | -2,636.89 | -1,018.24 | -29,099.08 | -1,938.27 | -429.87 | -197.15 | 17.46 | 40.56 | -2.75 | |
| Operating Margin | -37.49 | -198.70 | -220.12 | -695.86 | -590.95 | -827.69 | -2,594.40 | -1,002.51 | -29,359.33 | -1,870.20 | -344.95 | -161.59 | 30.60 | 39.23 | -15.94 | |
|
EPS Growth
|
-44.74 | 8.19 | 44.17 | -5.67 | 17.07 | -1.47 | 5.80 | 10.15 | 38.01 | -40.88 | 17.65 | 56.67 | 168.13 | 274.19 | -102.14 | |
| EPS USD | -757.00 | -695.00 | -388.00 | -410.00 | -340.00 | -345.00 | -325.00 | -292.00 | -181.00 | -255.00 | -210.00 | -91.00 | 62.00 | 232.00 | -4.96 | |
| Return on Assets (ROA) | -60.56 | -68.02 | -36.24 | -50.05 | -32.61 | -65.60 | -49.30 | -102.52 | -43.49 | -75.35 | -54.25 | -25.98 | 7.38 | 29.74 | -0.64 | |
| Return on Equity (ROE) | -479.38 | -109.97 | -48.66 | -60.92 | -35.81 | -90.29 | -57.08 | -126.06 | -47.68 | -251.96 | -1,826.26 | -156.37 | 34.50 | 50.46 | -1.03 | |
| Return on Invested Capital (ROIC) | -65.08 | -87.11 | -43.11 | -54.96 | -34.19 | -83.82 | -55.91 | -120.79 | -48.84 | -95.74 | -52.92 | -33.18 | 27.74 | 33.66 | -6.16 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 33.38 | 13.99 | 9.55 | 6.92 | 3.83 | 5.30 | - - | - - | - - | 47.83 | 78.65 | 61.67 | 24.77 | 26.17 | 25.77 | |
| Debt/Equity | 264.26 | 22.61 | 12.83 | 8.42 | 4.20 | 7.30 | - - | - - | - - | 159.95 | 2,647.59 | 371.16 | 115.74 | 44.41 | 41.30 | |
| Debt/EBITDA | 222.98 | 28.81 | 40.87 | 11.24 | 35.48 | 44.06 | 42.86 | 21.94 | 29.79 | -34.45 | -153.84 | -276.64 | -125.67 | 18.78 | 508.29 | |
|
Debt/Capitalization
|
72.55 | 18.44 | 11.37 | 7.77 | 4.03 | 6.80 | - - | - - | - - | 61.53 | 96.36 | 78.78 | 53.65 | 30.75 | 29.23 | |
| Long-Term Debt/Capitalization | 59.44 | 18.44 | - - | - - | - - | 8.69 | - - | - - | - - | 61.53 | 96.31 | 78.52 | 53.40 | 30.45 | 28.86 | |
| Interest Debt per Share USD | 4.21 | 1.63 | 1.18 | 0.71 | 0.40 | 0.28 | 0.02 | -0.01 | - - | 1.77 | 3.28 | 2.35 | 2.31 | 2.09 | 2.05 | |
| Debt Growth | - - | 26.12 | 8.73 | -100.00 | - - | - - | -100.00 | - - | - - | - - | 114.58 | 0.65 | 18.15 | 0.24 | -0.43 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 268.56 | 506.87 | 457.83 | 658.09 | 1,188.11 | 604.82 | 681.34 | 406.34 | 1,031.86 | 432.67 | 362.67 | 295.47 | 109.15 | 455.67 | 1,381.33 | |
| Quick Ratio | 259.81 | 497.62 | 453.68 | 663.38 | 1,179.61 | 608.41 | 686.19 | 413.04 | 1,036.45 | 392.40 | 301.51 | 242.47 | 121.81 | 514.35 | 1,265.11 | |
| Cash Ratio | 253.63 | 152.73 | 117.35 | 39.97 | 142.80 | 244.15 | 155.68 | 121.23 | 142.98 | 129.75 | 75.19 | 41.43 | 78.39 | 134.60 | 241.63 | |
| Operating Cash Flow Ratio | -200 | -300 | -100 | -200 | -300 | -300 | -300 | -500 | -400 | -300 | -200 | -100 | - - | - - | 100 | |
| Turnover | ||||||||||||||||
| Inventory Turnover | - - | - - | - - | - - | - - | - - | - - | - - | 382.69 | 114.58 | 46.91 | 21.84 | 282.99 | 440.99 | 94.14 | |
| Receivables Turnover | 4,504.80 | 2,392.61 | 226.87 | 966.57 | 691.52 | 1,517.47 | 290.53 | 822.88 | 38.29 | 221.33 | 396.34 | 205.42 | 333.38 | 489.91 | 521.60 | |
| Payables Turnover | 58.13 | 42.08 | 14.66 | - - | - - | - - | - - | - - | 26.31 | 412.96 | 208.98 | 419.99 | 6,675.85 | 8,164.22 | 956.47 | |
|
Asset Turnover
|
79.89 | 28.43 | 16.12 | 6.95 | 5.50 | 7.98 | 1.87 | 10.07 | 0.15 | 3.89 | 12.62 | 13.18 | 42.28 | 73.31 | 23.30 | |
| Fixed Turnover | 504.16 | 373.99 | 350.71 | 121.96 | 129.23 | 139.22 | 29.34 | 64.30 | 1.97 | 48.04 | 109.98 | 81.45 | 720.59 | 1,140.94 | 377.18 | |
| Coverage | ||||||||||||||||
| Interest Coverage | -12,189.52 | -2,877.21 | -2,431.12 | -2,875.20 | - - | -260,888.57 | -18,369.41 | 19,354.37 | - - | -1,641.88 | -715.60 | -394.62 | 1,203.35 | 4,211.56 | -547.99 | |
| Asset Coverage | 400 | 500 | 900 | - - | - - | 1,200 | - - | - - | - - | 100 | 100 | 100 | 100 | 300 | 300 | |
| Cash Flow Coverage (CFGR) | -199.13 | -436.00 | -367.81 | -453.18 | -749.53 | -1,005.98 | - - | - - | - - | -130.17 | -55.24 | -42.35 | 130.36 | 24.31 | 39.14 | |
| EBITDA Coverage | -9,900 | -2,200 | -2,300 | -2,800 | - - | -259,100 | -18,200 | 19,300 | - - | -1,600 | -600 | -300 | 1,200 | 4,400 | 300 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 200 | 200 | - - | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -53.35 | -21.72 | -11.70 | -14.40 | -17.34 | -20.47 | -13.44 | -73.93 | -9.67 | -27.85 | -36.75 | -20.47 | 4.69 | 21.80 | -0.36 | |
|
Price/Earnings (P/E)
|
-187.46 | -460.46 | -854.65 | -694.56 | -576.60 | -488.56 | -743.87 | -135.27 | -1,033.97 | -359.10 | -272.12 | -488.53 | 2,132.41 | 458.76 | -28,168.53 | |
| Price/Earnings Growth (PEG) | -4.19 | 56.22 | 19.35 | -122.49 | 33.77 | -332.22 | 128.32 | 13.32 | 27.20 | -8.78 | 15.42 | 8.62 | -12.68 | 1.67 | 275.79 | |
|
Price/Book (P/B)
|
898.64 | 506.38 | 415.83 | 423.11 | 206.51 | 441.11 | 424.64 | 170.51 | 493.04 | 904.80 | 4,969.57 | 763.89 | 735.62 | 231.47 | 289.31 | |
| Price/Tangible Book (P/TB) | 898.64 | 506.38 | 415.83 | 423.11 | 206.51 | 441.11 | 424.64 | 170.51 | 493.04 | 904.80 | 4,969.57 | 763.89 | 735.62 | 231.47 | 289.31 | |
| Price/Sales (P/S) | 142.11 | 1,101.80 | 1,921.60 | 5,001.41 | 3,419.33 | 4,017.70 | 19,614.94 | 1,377.33 | 300,875.57 | 6,960.38 | 1,169.76 | 963.14 | 372.25 | 186.09 | 774.78 | |
|
Price/Cash Flow (P/CF)
|
-170.77 | -513.69 | -881.52 | -1,108.99 | -655.68 | -601.09 | -858.27 | -142.08 | -1,269.21 | -434.58 | -339.77 | -486.01 | 487.54 | 2,144.39 | 1,789.61 | |
| Price/Free CF (P/FCF) | -168.87 | -509.52 | -860.66 | -1,039.45 | -637.97 | -587.80 | -798.16 | -132.48 | -1,258.35 | -389.53 | -273.46 | -433.93 | 501.71 | 2,419.84 | 1,865.75 | |
| Price/Operating CF (P/OCF) | -170.77 | -513.69 | -881.52 | -1,108.99 | -655.68 | -601.09 | -858.27 | -142.08 | -1,269.21 | -434.58 | -339.77 | -486.01 | 487.54 | 2,144.39 | 1,789.61 |